Twitter | Pretraživanje | |
Andrew Dunn
Pharma and biotech reporter for Say hello: adunn@businessinsider.com
2.932
Tweetovi
998
Pratim
2.416
Osobe koje vas prate
Tweetovi
Andrew Dunn 14 h
Worth a read if you missed it earlier today: has a great explanation of Regeneron's coronavirus R&D plan
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 18 h
Vaccine efforts against will likely take years, with history as a guide. The hope with testing some antivirals already on market is that timeline could be much quicker in getting patients a treatment:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Lydia Ramsey 18 h
Fun one up this morning: I spoke to CEO about the three "R's" he's used to guide his career.
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Meg Tirrell 19 h
+13% on winning patent challenge to Tecfidera vs
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 19 h
Odgovor korisniku/ci @AndrewE_Dunn
A milestone in cancer and cloud genomics. “The broad availability and quality of the new data set will almost certainly spur a wave of biological insights.” write U-Mich. researchers Marcin Cieslik and Arul Chinnaiyan in a commentary piece here:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 19 h
Odgovor korisniku/ci @AndrewE_Dunn
Nature's main link isn't live yet, but here's an editorial describing the effort that is up:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 19 h
Nature just published 20+ papers based off one of the largest collaborative efforts in cancer research: 1,300+ scientists sequencing 2,658 whole genomes from 37 countries in 38 different tumor types. Full collection of Nature papers, out now:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 21 h
ICYMI: I wrote about the leading drug industry responses to the coronavirus epidemic. Includes and here:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 5. velj
Going into , here’s what Capital Alpha healthcare analysts wrote on if Trump makes no reference to the IPI model (he didn’t): “If Trump doesn’t make any decisive comments on the model, we’d question whether he has a viable plan for acting on it.”
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Adam Feuerstein 4. velj
on call: No knowledge of additional responses to remdesivir. Waiting for clinical data. On manufacturing capacity: “We are investing heavily to be prepared as best we can.”
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 4. velj
To say the least, this has been a fast-moving space. J&J, Regeneron, Gilead and others have all disclosed R&D plans for curing or treating the novel coronavirus. Here's the latest round-up on all their efforts:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Zachary Tracer 4. velj
real nice overview from on how big pharma is gearing up to fight the Wuhan coronavirus:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 4. velj
George Yancopoulos on coronavirus R&D efforts: "The life-saving results seen with our investigational Ebola therapy last year underscore the potential impact of Regeneron's rapid response platform for addressing emerging outbreaks." PR here:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 4. velj
a16z's growth in biotech/healthcare investing: 2015: $200m fund + hire Vijay Ponde 2017: $450m fund + add 2019: Add Julie Yoo as GP 2020: $750m fund + add Here's what the Bio Fund 3 team is targeting:
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
CNBC 3. velj
Coronavirus testing needs to be more widespread, former FDA Commissioner Dr. Scott Gottlieb says. “We have to assume it’s already here and circulating.”
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 31. sij
Simple — yet stunning — graphic to see. # of confirmed cases of coronavirus in China, per daily situation reports from WHO. Just under 25,000 cases if you add suspected cases in China.
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Lydia Ramsey 31. sij
This week's Dispensed is out! In it: - So much on + the primary care biz overall - 's insights from biotech/pharma earnings - my deep-dive on 's partnership strategy Subscribe!
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 31. sij
Just published in The Lancet: a new model by U. of Hong Kong researchers says 75,800 individuals in Wuhan may have been infected w/ coronavirus as of Jan. 25. Also says multiple major Chinese cities may have enough cases for local epidemics.
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 31. sij
Amgen's recent R&D on kidney disease hasn't brought "game-changing innovation," CEO Bob Bradway said yesterday, so is turning to M&A/BD to bring in external assets. up 8% today, a top Wall Street takeout target working in the kidney space.
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn proslijedio/la je tweet
Lydia Ramsey 31. sij
Here we go: One Medical is set to start trading today after raising $245 million in its IPO
Reply Retweet Označi sa "sviđa mi se"